Purchase Order HT942523P0062
Award Date 8/4/23
Potential Completion Date 10/5/23
Potential Value $500K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $630,846 contract is for the provision of a NEXTSEQ 550DX SEQUENCING SYSTEM, with a completion date of November 30, 2018. Illumina has a history of providing a range of sequencing equipment and supplies to federal agencies like the NIH, CDC, USDA, and VA for research and diagnostic purposes. Additionally, Illumina holds an...
- This firm fixed price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The $119,937.50 contract is for the procurement of replacement laboratory equipment, specifically next-generation sequencing systems and associated consumables, to support the agency's biodefense research and diagnostics efforts. Illumina has previously been awarded prime contracts and subcontracts across various federal...
- This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
- This is a $752,450 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract...
- This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
- This is a firm fixed price purchase order for $367,269.00 awarded by the Medical Command (MEDCOM) division of the U.S. Army to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a NextSeq 500 sequencing system, with an ultimate completion date of November 18, 2020. Illumina has provided similar sequencing systems and related products and services to various federal agencies like the NIH, CDC, USDA, and VA in the past. This award is not...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $68,512.50, is for the delivery of various Illumina sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models, along with accompanying reagents, consumables, and support services. The contract is not designated as a set-aside. Illumina has...
- This is a firm fixed-price delivery order awarded by the National Institutes of Health (NIH) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $149,632.54 order is for the provision of supplies and services related to Illumina's proprietary sequencing platforms, including the NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, and maintenance...
- This is a $863,550.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Illumina, Inc. for the provision of lab equipment, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and other consumables. Illumina is a manufacturer and provider of genomic sequencing and analysis solutions. The award has no set-aside designation. Illumina has a history of providing...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The contract, valued at $81,640.80, is for the provision of NEXTSEQ 500/500 sequencing systems and related catalog items. The award has no set-aside designation. Illumina has previously provided sequencing systems and services to support...